Formulation for Co-Administration of Q-GRFT and Tenofovir
US-2024374681-A1 · Nov 14, 2024 · US
Compositions and methods for treatment of pouchitis
US8946178B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8946178-B2 |
| Application number | US-201113299291-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 17, 2011 |
| Priority date | Feb 13, 2003 |
| Publication date | Feb 3, 2015 |
| Grant date | Feb 3, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates methods of treating pouchitis by administering a pharmaceutical formulation suitable for rectal use, such as an enema or suppository, comprising an antisense oligonucleotide targeted to ICAM-1 to an individual
First claim
Opening claim text (preview).
What is claimed is: 1. A method of treating pouchitis in a human, comprising: identifying a human having pouchitis; and rectally administering to said human a pharmaceutical composition, wherein said pharmaceutical composition comprises an antisense oligonucleotide that specifically hybridizes to and inhibits the activity of a human ICAM-1 mRNA, wherein said antisense oligonucleotide comprises from 16 to 20 phosphorothioate linked nucleosides that are each independently selected…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8946178B2 cover?
- The present invention relates methods of treating pouchitis by administering a pharmaceutical formulation suitable for rectal use, such as an enema or suppository, comprising an antisense oligonucleotide targeted to ICAM-1 to an individual
- Who is the assignee on this patent?
- Wedel Mark K, Miner Phillip B, Isis Pharmaceuticals Inc
- What technology area does this patent fall under?
- Primary CPC classification A61K9/0031. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).